
535 E 70th StNew York, NY 10021
Overview of Dr. Ghosh
Dr. Nilasha Ghosh is a rheumatologist based in New York, NY. She graduated from the University of California, Irvine, School of Medicine in 2015 and completed her residency in Internal Medicine at McGaw Medical Center of Northwestern University in 2018. Her clinical expertise includes arthritis, and she has contributed to several publications in the field of rheumatology, focusing on glucocorticoid therapy, inflammatory arthritis, and immune checkpoint inhibitors. Notably, she was inducted into the Alpha Omega Alpha Honor Medical Society, and her research work has been published in respected journals like Seminars in Arthritis and Rheumatism, Rheumatology, and The Journal of Arthroplasty.
Education & Training
- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2015 - 2018
- University of California, Irvine, School of MedicineClass of 2015
Certifications & Licensure
- NY State Medical License 2018 - 2027
- IL State Medical License 2017 - 2020
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society
Publications & Presentations
PubMed
- 1 citationsIncidence of checkpoint inhibitor-associated inflammatory arthritis, immunomodulation and mortality in cancer patients on immunotherapy: a retrospective cohort study.Anne R Bass, Fenglong Xie, Deanna Jannat-Khah, Nilasha Ghosh, Karmela K Chan
Rheumatology. 2025-04-01 - Prioritising domains of glucocorticoid therapy to measure in trials: Results from a modified delphi exercise from the OMERACT glucocorticoid impact working group.Joanna Tieu, Jonathan Tl Cheah, Suellen Lyne, Kevin Yip, Nilasha Ghosh
Seminars in Arthritis and Rheumatism. 2025-04-01 - 2 citationsThe Need for Classification Criteria of Immune Checkpoint Inhibitor-induced inflammatory Arthritis: A Scoping Review.Nilasha Ghosh, Bridget Jivanelli, Nina Couette, Namrata Singh, Marie Kostine
Rheumatic Diseases Clinics of North America. 2024-05-01
Press Mentions
- This Drug May Safely Treat Psoriasis Exacerbations from Cancer TherapyJuly 15th, 2025
- HSS Presents Rheumatoid Arthritis Research at 2022 EULAR Annual CongressJune 6th, 2022
- 11 Red-Flag Signs Your Rheumatoid Arthritis May Be Getting WorseSeptember 22nd, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: